2012 Aarkstore.com || Non alcoholic steatohepatitis – pipeline review, h2 2012

1. Aarkstore.com announces, The Latest market research report is available in
its vast collection:
Non-Alcoholic Steatohepatitis – Pipeline Review, H2 2012
You can also request for sample page of above mention reports on
sample@aarkstore.com
Summary
Global Markets Direct’s, Non-Alcoholic Steatohepatitis - Pipeline Review, H2 2012,
provides an overview of the Non-Alcoholic Steatohepatitis therapeutic pipeline. This
report provides information on the therapeutic development for Non-Alcoholic
Steatohepatitis, complete with latest updates, and special features on late-stage and
discontinued projects. It also reviews key players involved in the therapeutic
development for Non-Alcoholic Steatohepatitis. Non-Alcoholic Steatohepatitis -
Pipeline Review, H2 2012 is built using data and information sourced from Global
Markets Direct’s proprietary databases, Company/University websites, SEC filings,
investor presentations and featured press releases from company/university sites
and industry-specific third party sources, put together by Global Markets Direct’s
team.
Note*: Certain sections in the report may be removed or altered based on the
availability and relevance of data for the indicated disease.
Scope
- A snapshot of the global therapeutic scenario for Non-Alcoholic Steatohepatitis.
- A review of the Non-Alcoholic Steatohepatitis products under development by
companies and universities/research institutes based on information derived from
company and industry-specific sources.
Table of contents:

2. List of Tables 7
List of Figures 8
Introduction 9
Global Markets Direct Report Coverage 9
Non-Alcoholic Steatohepatitis Overview 10
Therapeutics Development 11
An Overview of Pipeline Products for Non-Alcoholic Steatohepatitis 11
Non-Alcoholic Steatohepatitis Therapeutics under Development by Companies 13
Non-Alcoholic Steatohepatitis Therapeutics under Investigation by
Universities/Institutes 16
Late Stage Products 18
Comparative Analysis 18
Mid Clinical Stage Products 19
Comparative Analysis 19
Early Clinical Stage Products 20
Comparative Analysis 20
Discovery and Pre-Clinical Stage Products 21
Comparative Analysis 21
Non-Alcoholic Steatohepatitis Therapeutics – Products under Development by
Companies 22
Non-Alcoholic Steatohepatitis Therapeutics – Products under Investigation by
Universities/Institutes 24
Companies Involved in Non-Alcoholic Steatohepatitis Therapeutics Development 25
Isis Pharmaceuticals, Inc. 25
Takeda Pharmaceutical Company Limited 26
Mochida Pharmaceutical Co., Ltd. 27
Genfit 28
Immuron Limited 29
List of Figures
List of Tables are also include.
For more related Reports Plz follow The link:

3. Pipeline Review, H2 2012
http://www.aarkstore.com/search/viewresults.asp?search=Pipeline Review, H2
2012&PubId=&pagenum=1
Male Cancer – Pipeline Review, H2 2012
Osteoarthritis Pain – Pipeline Review, H2 2012
Non-Alcoholic Steatohepatitis – Pipeline Review, H2 2012
Idiopathic Pulmonary Fibrosis – Pipeline Review, H2 2012
Peripheral Arterial Disease (PAD)/ Pulmonary Vascular Disease (PVD) – Pipeline
Review, H2 2012
Lymphoma – Pipeline Review, H2 2012
Acute Ischemic Stroke – Pipeline Review, H2 2012
Irritable Bowel Syndrome – Pipeline Review, H2 2012
Migraine – Pipeline Review, H2 2012
Female Infertility – Pipeline Review, H2 2012
Search More Reports Related to This Category :
Pharmaceuticals and Healthcare
http://www.aarkstore.com/search/viewresults.asp?search=Pharmaceuticals and
Healthcare&PubId=&pagenum=1

4. For More details Plz do contact :
Aarkstore Enterprise
Lavanya
Phone:08149852585
Email: enquiry@aarkstore.com